Estrogen reduces 11β-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats

Obesity

Volumn 18, Issue 3, 2010, Pages 470-475

  Andersson, Therése ^a   Söderström, Ingegerd ^a   Simonyté, Kotryna ^a   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; RATTUS;

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ESTRADIOL; ESTROGEN; PREGNANE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BODY FAT DISTRIBUTION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; ESTROGEN THERAPY; FEMALE; INTRAABDOMINAL FAT; LIVER; METABOLISM; OBESITY; OVARIECTOMY; PHYSIOLOGY; POSTMENOPAUSE; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS FAT; WEIGHT GAIN;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BODY FAT DISTRIBUTION; DOWN-REGULATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; INTRA-ABDOMINAL FAT; LIVER; OVARIECTOMY; POSTMENOPAUSE; PREGNENEDIONES; RATS; RATS, SPRAGUE-DAWLEY; SUBCUTANEOUS FAT; WEIGHT GAIN;

EID: 77249107754     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.294     Document Type: Article

References (47)

1. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
2. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008;32:949-958.
3. Meli R, Pacilio M, Raso GM et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004;145:3115-3121.
4. Paulsen SK, Nielsen M P, Richelsen B et al. Upregulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) 2008;16:731-735.
5. Sanchez-Mateos S, Alonso-Gonzalez C, Gonzalez A et al. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. Maturitas 2007;58:91-101.
6. Dubuc PU. Effects of estradiol implants on body weight regulation in castrated and intact female rats. Endocrinology 1974;95:1733-1736.
7. Genazzani AR, Gambacciani M. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 2006;22:145-150.
8. Tomlinson JW, Walker EA, Bujalska IJ et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004;25:831-866.
9. Kalleinen N, Polo-Kantola P, Irjala K et al. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre-and postmenopausal women: the effect of combined estrogen and progestin treatment. J Clin Endocrinol Metab 2008;93:1655-1661.
10. Walker BR, Andrew R. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann NY Acad Sci 2006;1083:165-184.
11. Masuzaki H, Paterson J, Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
12. Masuzaki H, Yamamoto H, Kenyon CJ et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83-90.
13. Paterson JM, Morton NM, Fievet C et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 2004;101:7088-7093.
14. Kotelevtsev Y, Holmes MC, Burchell A et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 1997;94:14924-14929.
15. Low SC, Assaad SN, Rajan V et al. Regulation of 11beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 1993;139:27-35.
16. Low SC, Chapman KE, Edwards CR et al. Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J Endocrinol 1994;143:541-548.
17. Paulsen SK, Pedersen SB, Fisker S, Richelsen B. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007;15:1954-1960.
18. Dieudonné MN, Sammari A, Dos Santos E et al. Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J Steroid Biochem Mol Biol 2006;99:189-196.
19. Engeli S, Böhnke J, Feldpausch M et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004;12:9-17.
20. Friedberg M, Zoumakis E, Hiroi N et al. Modulation of 11beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J Clin Endocrinol Metab 2003;88: 385-393
21. Söderström I, Strand M, Ingridsson AC, Nasic S, Olsson T. 17beta-estradiol and enriched environment accelerate cognitive recovery after focal brain ischemia. Eur J Neurosci 2009;29:1215-1224.
22. Björnheden T, Jakubowicz B, Levin M et al. Computerized determination of adipocyte size. Obes Res 2004;12:95-105.
23. Lakshmi V, Monder C. Purification and characterization of the corticosteroid 11beta-dehydrogenase component of the rat liver 11beta-hydroxysteroid dehydrogenase complex. Endocrinology 1988;123:2390-2398.
24. Burén J, Bergström SA, Loh E et al. Hippocampal 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat. Endocrinology 2007;148:2716-2722.
25. Livingstone DE, Jones GC, Smith K et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-563.
26. Tchernof A, Poehlman ET, Després J P. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000;26:12-20.
27. Rodriguez-Cuenca S, Monjo M, Proenza AM, Roca P. Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am J Physiol Endocrinol Metab 2005;288:E200-E207.
28. Anwar A, McTernan PG, Anderson LA et al. Site-specific regulation of oestrogen receptor-alpha and-beta by oestradiol in human adipose tissue. Diabetes Obes Metab 2001;3:338-349.
29. Dieudonné MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 2004;286:C655-C661.
30. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. J Endocrinol 1999;160:103-109.
31. Pinilla L, Seoane LM, Gonzalez L et al. Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol 1999;140:468-473.
32. Tanaka M, Nakaya S, Kumai T et al. Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue in rats. Horm Res 2001;56:98-104.
33. Rask E, Olsson T, Söderberg S et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86:1418-1421.
34. Rask E, Walker BR, Söderberg S et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002;87:3330-3336.
35. Drake AJ, Livingstone DE, Andrew R et al. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 2005;146:913-919.
36. Arai K, Soga T, Ohata H, Otagiri A, Shibasaki T. Effects of food restriction on peroxisome proliferator-activated receptor-gamma and glucocorticoid receptor signaling in adipose tissues of normal rats. Metab Clin Exp 2004;53:28-36.
37. Mariniello B, Ronconi V, Rilli S et al. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome. Eur J Endocrinol 2006;155:435-441.
38. Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 2001;288:191-197.
39. Michailidou Z, Jensen MD, Dumesic DA et al. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 2007;15:1155-1163.
40. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000;43:1498-1506.
41. D'Eon TM, Souza SC, Aronovitz M et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005;280:35983-35991.
42. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000;97:12729-12734.
43. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004;5:197-216.
44. Bergö M, Olivecrona G, Olivecrona T. Diurnal rhythms and effects of fasting and refeeding on rat adipose tissue lipoprotein lipase. Am J Physiol 1996;271:E1092-E1097.
45. Dziennis S, Jia T, Rønnekleiv OK, Hurn PD, Alkayed NJ. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci 2007;27:7268-7274.
46. Rusa R, Alkayed NJ, Crain BJ et al. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999;30:1665-1670.
47. Zhao H, Tian Z, Hao J, Chen B. Extragonadal aromatization increases with time after ovariectomy in rats. Reprod Biol Endocrinol 2005;3: 6.